Day One Biopharmaceuticals Inc (DAWN)
SG&A Expense Growth
21.32%
Quarterly · Period ending:
DAWN SG&A Expense Growth
Latest reported21.32%period ending
Latest reported21.32%period ending
DAWN Quarterly SG&A Growth (QoQ) (0.00% → 21.32%)
Latest values, visible window
High-resolution chart · PNG
DAWN sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 21.3167% | |
| -2.8342% | |
| -1.2174% | |
| -1.3788% | |
| 2.6336% | |
| -4.0217% | |
| 13.6649% | |
| 19.7934% | |
| 21.3078% | |
| 7.0466% | |
| -5.2976% | |
| 7.7976% | |
| -5.3272% | |
| 24.7546% | |
| 11.0945% | |
| 18.1624% | |
| 14.8424% | |
| 69.991% | |
| 59.9595% | |
| 74.5326% | |
| 93.2617% | |
| 17.4312% | |
| 7.9208% | |
| 0% |